Tenosynovial giant cell tumour (TGCT) is a benign fibrohistiocytic proliferation that can lead to intraarticular inflammation causing secondary degenerative arthropathy. Surgery is the preferred treatment to avoid complications. Paediatric TGCT is rarely reported, mostly in case studies. This revision presents the largest paediatric series. This observational study involved 24 paediatric patients reported between 1998 and 2023 with confirmed histological diagnosis of TGCT. Descriptive statistics were used for analysis. Twenty-four patients (mean age 12.25 years, SD 3.78; 1:1 gender ratio) were included with the anatomopathological diagnosis of TGCT. The knee was the most affected joint (75%), with localized nodular presentation (66.7%). Initial symptoms were mechanical pain in all patients, joint effusion in 79.1%, and limp in 25%. Mean duration of symptom duration before diagnosis was 9 months (range 4–15). Magnetic Resonance Imaging (MRI) findings were consistent with TGCT in all cases, and alter confirmed by arthroscopic biopsy. Radiographs showed soft tissue changes in five patients. Treatment included arthroscopic synovectomy (70.8%) or open surgery (29.2%). Over a mean follow-up of 98 months (range 6–288), six recurrences occurred, all with diffuse presentation at the knee. Conclusion: MRI is the preferred method for diagnosis and follow-up. Surgery is the main treatment, with low recurrence if nodular lesions are accurately removed. Outcomes and recurrence depend on diffuse presentation. We recommend open surgery for recurrences and local adjuvant treatment.<Table Float="No" ID="Taba"> <tgroup cols="1"> <colspec align="left" colname="c1" colnum="1" /> <tbody> <row> <entry align="left" colname="c1"> What is Known: • Tenosynovial Giant Cell Tumour (TGCT) is an uncommon benign synovial lesion usually described as isolated case reports in children. • MRI is the preferred imaging technique due its superior tissue contrast and ability to differentiate diffuse and localized forms. </entry> </row> <row> <entry align="left" colname="c1"> What is New: • We present the largest known pediatric series of TGCT including 24 histolgically confirmed cases and with outcome data. • The study provides insight into recurrence patterns and supports a tailored surgical approach based on lesion type. </entry> </row> </tbody> </tgroup> </Table>

Tenosynovial giant cell tumour in children. Our experience with 24 patients in a third level Children’s Hospital, an observational study

期刊论文
发表日期：

2025年9月20日

查看全文

David Moreno-Romo,
Emilio J Inarejos-Clemente,
Ferran Torner-Rubies,
Laura M. Perez-Lopez,
Adria Guerris-Fernandez,
Rocio G. Garcia

摘要

Tenosynovial giant cell tumour (TGCT) is a benign fibrohistiocytic proliferation that can lead to intraarticular inflammation causing secondary degenerative arthropathy. Surgery is the preferred treatment to avoid complications. Paediatric TGCT is rarely reported, mostly in case studies. This revision presents the largest paediatric series. This observational study involved 24 paediatric patients reported between 1998 and 2023 with confirmed histological diagnosis of TGCT. Descriptive statistics were used for analysis. Twenty-four patients (mean age 12.25 years, SD 3.78; 1:1 gender ratio) were included with the anatomopathological diagnosis of TGCT. The knee was the most affected joint (75%), with localized nodular presentation (66.7%). Initial symptoms were mechanical pain in all patients, joint effusion in 79.1%, and limp in 25%. Mean duration of symptom duration before diagnosis was 9 months (range 4–15). Magnetic Resonance Imaging (MRI) findings were consistent with TGCT in all cases, and alter confirmed by arthroscopic biopsy. Radiographs showed soft tissue changes in five patients. Treatment included arthroscopic synovectomy (70.8%) or open surgery (29.2%). Over a mean follow-up of 98 months (range 6–288), six recurrences occurred, all with diffuse presentation at the knee. Conclusion: MRI is the preferred method for diagnosis and follow-up. Surgery is the main treatment, with low recurrence if nodular lesions are accurately removed. Outcomes and recurrence depend on diffuse presentation. We recommend open surgery for recurrences and local adjuvant treatment.

What is Known:

• Tenosynovial Giant Cell Tumour (TGCT) is an uncommon benign synovial lesion usually described as isolated case reports in children.

• MRI is the preferred imaging technique due its superior tissue contrast and ability to differentiate diffuse and localized forms.

What is New:

• We present the largest known pediatric series of TGCT including 24 histolgically confirmed cases and with outcome data.

• The study provides insight into recurrence patterns and supports a tailored surgical approach based on lesion type.